$XPEV

Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Lexicon Pharmaceuticals (NASDAQ:LXRX), Dell Technologies (NYSE:DELL)

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of Xpeng Inc - ADR ( NYSE:XPEV ) fell sharply in pre-market trading after the company reported third-quarter financial results.

Original reporting
Benzinga · Avi Kapoor
Published Nov 17, 2025, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 17, 2025, 1:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Lexicon Pharmaceuticals (NASDAQ:LXRX), Dell Technologies (NYSE:DELL) — source image
Decision brief

The 30-second read

$XPEVBearishMed
01

Why it matters

Negative earnings reports and currency depreciation are contributing to the bearish sentiment in affected stocks and sectors.

02

Market read

The news highlights short-term market movements driven by earnings and currency trends, with potential implications for related sectors and international trade.

03

What to watch

Potential positive catalysts include upcoming earnings reports or macroeconomic data that could reverse current bearish sentiment.

Timing: Immediate to short-term

Background

The article reports on pre-market stock movements influenced by quarterly earnings and macroeconomic factors.

Company-level read

Ticker impact

$XPEVBearishMedium confidence
Context

High relevance due to recent financial results and significant pre-market price movement.

Expected impact

Potential further decline in the short term, with a possible test of recent support levels.

Evidence & confidence

Financial results have negatively impacted sentiment, and pre-market trading indicates bearish momentum. However, lack of detailed technical analysis limits certainty.

$LXRXBearishLow confidence
Context

Moderate relevance as the stock shows a somewhat-bearish sentiment but limited immediate price movement.

Expected impact

Likely stable in the near term with potential for slight declines if broader market weakness persists.

Evidence & confidence

Sentiment is somewhat bearish, but low relevance and trading volume reduce the impact.

$DELLBearishMedium confidence
Context

Moderate relevance; somewhat-bearish sentiment but stable fundamentals.

Expected impact

Potential for minor declines, but overall stability expected.

Evidence & confidence

Fundamental stability reduces risk despite sentiment.

Market effects

Technology and automotive sectors may experience short-term volatility due to stock movements.

US markets are likely to open slightly lower, influenced by pre-market declines.

Moderate; currency movements and international trade implications could influence global indices.

Counterpoint

The decline may be a short-term correction within an overall bullish trend, especially if broader market sentiment improves.

Key entities

  • Xpeng Inc

    Chinese electric vehicle manufacturer experiencing a sharp decline post-earnings.

  • Dell Technologies

    Major technology firm showing slight bearishness amid broader market trends.

  • CNY

    Chinese Yuan, experiencing depreciation impacting international trade.

Related articles

$SMCIMed

Super Micro, Dell, and HP Jump After Strong Lenovo Earnings

After Lenovo reported strong AI server demand, shares of AI hardware makers rose. Lenovo revenue grew 43% YoY to $26.94B, AI revenue rose 60% to $9.3B, and its AI server pipeline jumped 157% sequentially to $54B. Super Micro guided FY27 revenue $65B-$72B; Dell, HPE, and HPQ also gained.

$LXRXMed

Lexicon (LXRX) Q2 2026 Earnings Call Transcript

Lexicon (LXRX) discussed its Q2 2026 earnings call, focusing on sotagliflozin. The company said SONATA-HCM enrollment is complete and the trial was overenrolled, with top-line results expected in Q1 2027. For Zynquista, Lexicon said FDA resubmission criteria may be met after STENO1 reaches exposure targets by end of August, targeting an NDA resubmission in Q4 2026. It also noted Viatris regulatory progress for sotagliflozin and Novo Nordisk’s Phase I for 9851.

$DELLMed

Why is Dell Technologies stock surging today?

Dell Technologies shares rose about 4% pre-open to around $504. The move followed Super Micro Computer’s fiscal 2027 revenue guidance above consensus and Lenovo’s stronger fiscal Q1 results. Goldman Sachs reiterated a Buy rating and raised its 12-month target to $510, while Morgan Stanley cut its target to $430.